Status:
NOT_YET_RECRUITING
Impact of Gastric Mesentery With Lymph Node Metastasis on Prognosis in Gastric Cancer Patients
Lead Sponsor:
Jichao Qin
Collaborating Sponsors:
Zhejiang University
Conditions:
Gastric Carcinoma
Eligibility:
All Genders
18-85 years
Brief Summary
This study aims to validate the predictive value of lymph node-metastasis gastric mesenteric regions and their quantitative involvement for gastric cancer prognosis by systematically examining lymph n...
Detailed Description
Prior to 2010, the gastric cancer nodal staging systems primarily consisted of two approaches: the UICC/AJCC classification (by the International Union Against Cancer/American Joint Committee on Cance...
Eligibility Criteria
Inclusion
- Aged older than 18 years and younger than 85 years
- Primary gastric adenocarcinoma confirmed by preoperative pathology result
- cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition
- Patients who received gastrectomy with D2 lymphadenectomy plus complete mesogastric excision
- American Society of Anesthesiologists (ASA) class I, II, or III
- Written informed consent
Exclusion
- Negative preoperative biopsy
- Too late tumour stage or metastasis (cT4b/M1)
- BMI\>30 kg/m2
- Total gastrectomy or proximal gastrectomy
- previous neoadjuvant chemotherapy or radiotherapy
- Previous upper abdominal surgery
- Combined with other malignant diseases
- Reject operation
Key Trial Info
Start Date :
August 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2030
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT07139418
Start Date
August 30 2025
End Date
August 30 2030
Last Update
August 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.